Gapping down
In reaction to disappointing earnings/guidance:
- EFII -32%, AAOI -24.6%, PI -21.7%, NGVC -21.3%, CFMS -20.8%, ABTL -20%, INFN -17.3%, GST -16.1%, MEET -12.2%, SYNA -11.2%, FLR -11.1%, CARB -9.6%, VIAB -9.6%, MELI -9%, BIO -8.9%, YRCW -8.6%, INFI -7.4%, CTRL -7%, NPTN -6.5%, APPN -6.4%, OVAS -6%, BGS -5.4%, VTL -5.1%, SMCI -4.8%, BNFT -4.6%, AXDX -4.3%, INTT -4.3%, HBM -3.8%, OESX -3.8%, ED -3.7%, NWL -3.7%, AG -3.5%, ACLS -3.4%, GRUB -3.3%, (GrubHub and Yelp (YELP) announce long-term partnership designed to capitalize on each company's unique assets and propel online takeout and delivery; GRUB to acquire Eat24 for 287.5 mln in cash ), HTGC -2.9%, UEIC -2.8%, VVUS -2.7%, RLJ -2.3%, AL -2.3%, PBPB -2.3%, WCG -2.2%, GSAT -2%, UE -1.9%, (also to sell 6.25 mln common shares to Cohen & Steers), TTPH -1.9%, NE -1.7%, ATVI -1.7%, NYMT -1.6%, CERS -1.6%, LOCO -1.5%, SWN -1.5%, SM -1.2%, INGN -1.2%, CLNE -1.1%, JUNO -1.1%, ESNT -1%, .
Select AAOI peers showing weakness:
- IPHI -3.8%, LITE -2.5%, OCLR -1.7%, FNSR -1.2%, IIVI -0.6%
Other news:
- IDN -21.1% ( commences common stock offering)
- APLP -11.5% (prices offering of 4 mln common units representing limited partner interests at $13.75 per common unit)
- DVAX -5.9% (U.S. Regulatory Update on HEPLISAV-B(TM) Following FDA Advisory Committee Meeting -- FDA has requested more detailed information about the company's proposed post-marketing study for HEPLISAV-B )
- AAXN -3.1% (Digital Ally announces 'yet another significant victory in its legal battles against Axon Enterprise')
- DGLY -2.7% (Digital Ally announces 'yet another significant victory in its legal battles against Axon Enterprise')
- BAS -1.7% (commenced at-the-market public offering of up to $50 million of its common stock pursuant to an effective shelf registration statement)
- ONCE -1% (prices underwritten public offering of 4,605,264 shares of its common stock at $76/share with net proceeds of ~$330.8 mln)
Analyst comments:
- HTGC -2.9% (downgraded to Underperform from Mkt Perform at Raymond James)